Search All News
The latest advance in radiation therapy—using AI to adjust treatments as needed—is now available for select cancer patients at Columbia University Irving Medical Center/NewYork-Presbyterian.
Columbia University Irving Medical Center has been selected by the National Organization for Rare Disorders to join a national network aimed at improving patient care for people with rare diseases.
Columbia research finds that some cases of OCD are caused by damaging gene variants that, while rare, provide a needed starting point for the development of better therapeutics.
A new analysis of almost 10,000 patients found that tumors could be stratified into 112 subtypes regardless of the cancer’s origin.
- October 29, 2020
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
- May 15, 2020
Lowering testosterone may prevent the new coronavirus from entering lung cells and lessen COVID-19 severity, new Columbia University research suggests. A trial has now begun in three VA hospitals.
- April 2, 2020
Based on the book by Columbia oncologist Siddhartha Mukherjee, the documentary also features Wendy Chung, David Goldstein, Samuel Sternberg, and Nancy Wexler. The two-part series airs April 7 and 14.
- April 30, 2019
In a series of new articles, Columbia physicians and researchers offer insight into the power and pitfalls of precision medicine in clinical practice.
- February 1, 2019
A study from Columbia University researchers suggests that DNA sequencing can help diagnose the underlying genetic causes of fetal anomalies found during prenatal ultrasounds.
- December 26, 2018
DNA sequencing can be used to identify the underlying genetic cause of many rare types of chronic kidney disease, leading to better treatment, finds a new study from Columbia University.
- July 5, 2018
New software may speed genetic diagnoses by automatically reviewing physician notes in electronic health records to identify candidate genes.